
Sixty Degree Capital
Description
Sixty Degree Capital is a Toronto-based venture capital firm dedicated to fostering innovation within the technology and healthcare sectors. Founded with a focus on early-stage companies, the firm aims to partner with visionary entrepreneurs who are developing disruptive solutions to complex challenges. Their investment philosophy emphasizes long-term partnerships, providing not just capital but also strategic guidance and access to a robust network to help portfolio companies scale effectively.
The firm primarily targets Seed and Series A funding rounds, seeking out companies that demonstrate strong potential for growth and significant market impact. Within healthcare, Sixty Degree Capital shows a particular interest in digital health, health tech, and solutions that improve patient outcomes or healthcare efficiency. In technology, their scope is broad, encompassing various software and platform innovations that can drive digital transformation. Notable companies in their portfolio include SeamlessMD, a digital health platform for surgical care, and MedStack, which provides a secure and compliant cloud platform for healthcare applications.
As of early 2024, Sixty Degree Capital has made approximately 10 investments, demonstrating a focused approach to its portfolio construction. The firm has also taken on the role of lead investor in at least 1 of these funding rounds, indicating a willingness to take a significant position in promising ventures. While specific typical check sizes are not publicly disclosed, their participation in early-stage rounds suggests investments aligned with the capital needs of Seed and Series A companies in the Canadian market. Sixty Degree Capital remains an active participant in the Canadian innovation ecosystem, committed to supporting the next generation of tech and health leaders.
Investor Profile
Sixty Degree Capital has backed more than 31 startups, with 3 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series E rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, Israel.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (35%)
- Series C (16%)
- Series E (13%)
- Series D (13%)
- Series Unknown (10%)
- Series A (6%)
- Convertible Note (3%)
- Seed (3%)
Country Focus
- United States (81%)
- Switzerland (10%)
- Israel (3%)
- Germany (3%)
- Canada (3%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Biopharma
- Pharmaceutical
- Medical
- Software
- Life Science
- Precision Medicine
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.